3 citations
,
July 2017 in “International journal of medicine” In this study, 70 patients with alopecia areata who received intralesional triamcinolone showed a significant reduction in black dots, yellow dots, broken hair, and tapering hair, while achieving a 60% success rate in hair regrowth.
60 citations
,
October 2009 in “PubMed” This study reports that intralesional triamcinolone acetonide was effective and well-tolerated for treating extensive alopecia areata in patients who often showed specific initial hair characteristics.
39 citations
,
March 1976 in “British Journal of Dermatology” This article reviews the use of intralesional steroid therapy in dermatology, highlighting its application in conditions like nail disorders and cystic acne, but it reports no new clinical results.
35 citations
,
January 2013 in “Indian Journal of Dermatology, Venereology and Leprology” This study found that intralesional triamcinolone acetonide is effective for treating localized patchy alopecia areata, with dermoscopy aiding in early detection of clinical response and adverse effects.
October 2024 in “Journal of Pakistan Association of Dermatologists” This study found that intralesional triamcinolone was more effective than the 308 nm Excimer laser in achieving >75% hair regrowth in patients with localized alopecia areata over 12 weeks.
2 citations
,
December 2020 in “American Journal of Dermatological Research and Reviews” This study found that combining 308-excimer phototherapy with intramuscular triamcinolone acetonide was effective and well tolerated for treating resistant alopecia totalis, showing a 90% overall response rate in the ten patients studied, with the best results observed in younger patients.